Form 4 for GLUE Monte Rosa Therapeutics, Inc.
Accepted 2026-06-25 16:05:03 ET · period of report 2026-06-23 · accession 0001193125-26-282736 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-06-25 16:05 | 2026-06-23 | GLUE | Townson Sharon | CSO | M - OptEx | $6.14 | +3,000 | 70.8K | +4% | +$18.4K |
| DT | 2026-06-25 16:05 | 2026-06-23 | GLUE | Townson Sharon | CSO | S - Sale+OE | $20.00 | -3,000 | 67.8K | -4% | -$60.0K |
| DT | 2026-06-25 16:05 | 2026-06-23 | GLUE | Townson Sharon | CSO | M - OptEx | $0.00 | -3,000 | 203.3K | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-23 | M | A | 3,000 | $6.14 | 70,845 | D | — | — | (F1) These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2026. |
| 2 | Common | Common Stock | 2026-06-23 | S | D | 3,000 | $20.00 | 67,845 | D | — | — | (F1) These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2026. |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-06-23 | M | D | 3,000 | $0.00 | 203,290 | D | $6.14 · — to 2031-04-12 | 3,000 Common Stock | (F1) These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2026. (F2) The shares underlying this option are fully vested and exercisable. |